Conformis sues Zimmer Biomet for patent infringement

Conformis (CFMS +2.7%) filed a lawsuit yesterday in a Delaware district court against Zimmer Biomet Holdings (ZBH +1.1%) claiming the latter’s personalized systems for knees, shoulders and hips infringe on four of its patents covering patient-specific instrument systems. It seeks cash compensation, including royalties on sales of the related ZBH products.

Last year, Smith & Nephew agreed to pay CFMS $10.7M to settle a similar dispute.


Leave a Reply